Beske joins Getinge from Philips where she most recently served as Senior Vice President, Business Unit Leader for Image Guided Therapy Devices
Read MoreExecutives On the Move
Ryan Steines Appointed CFO of Patterson Companies
Ryan brings more than 25 years of strategic, operational and capital allocation expertise to support the company's next phase of growth
Read MoreKevin Sayer Joins Guardant Health Board of Directors
Sayer has played a pivotal role in advancing innovations that have transformed how people monitor and manage disease and has a strategic and operations record delivering significant growth
Read MoreBioArctic’s Nomination Committee appointed
The Nomination Committee has been appointed in accordance with the principles adopted by the Annual General Meeting and consists of representatives of the three largest shareholders by voting rights as of September 30, 2026, as well as the Chair of the Board (convener)
Read More
Dave Larcenaire Named General Manager of Allient Denver
Dave brings more than 30 years of experience in precision motion, automation and advanced technology markets.
Read More
Catherine Jennings Named President of Beckman Coulter Diagnostics
Jennings brings more than 20 years of healthcare industry leadership experience and a proven track record of driving growth, innovation and transformation across global healthcare organizations
Read MoreRiccardo Fava Appointed New Group VP Investor Relations, Sustainability & Media Relations at Medacta
Riccardo Fava brings more than 20 years of experience across the medtech and financial sectors.
Read MoreProfessor Bill Sessa Appointed Chair of Isomab’s Scientific Advisory Board
Former Chief Scientific Officer of Internal Medicine at Pfizer: Leading vascular biologists from Yale, Harvard, Uppsala and the University of Eastern Finland join Sessa to advise on the development of ISM-001, Isomab's first-in-class anti-VEGF-A165b antibody for chronic angina
Read More
Ashlyn Tapley Promoted VP of Sales at Lavior
Expanded role includes leadership of U.S. sales and oversight of select international markets
Read MoreRobert Plenge MD, Ph.D., Appointed Chief Research Officer of Bristol Myers Squibb, to Board of Directors
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that the company has appointed Robert Plenge MD., Ph.D., to the company’s Board of Directors, effective September 10, 2026. Robert Plenge MD on Advancements in Genetic Research Dr. Plenge is Executive Vice President, Chief Research Officer and Head of Research at Bristol Myers Squibb,...
Read More
Perry Ann Reed Named Interim Senior Vice President and Chief Development Officer at Phoenix Children’s
Perry Ann Reed succeeds Steve Schnall, who will retire Sept. 30 after 43 years at Phoenix Children's
Read MoreR3 Vascular Expands Management Team with 2 Senior Executives
Appointments Support Accelerated Trial Enrollment, Market Development, Scalability, and Future Commercialization
Read More